Establishment Labs Holdings (ESTA) Prices 2.286M Share Common Offering at $26.25/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Pre-Open Stock Movers 01/29: (LEE) (LB) (GE) Higher (BHVN) (EXTR) (XLNX) Lower (more...)
January 29, 2020 9:22 AM ESTToday's Pre-Open Stock Movers
Lee Enterprises, Incorporated (NYSE: LEE) 53% HIGHER; entered into a definitive agreement with Berkshire Hathaway to acquire BH Media Groups (BHMG) publications and The Buffalo News for $140 million in cash. Berkshire Hathaway is providing approximately $576 million in long-term financing to Lee at a 9% annual rate. The proceeds from the Berkshire financing will be used to pay for the acquisition, refinance Lees approximately $400 million of existing debt, and provide enough cash on Lees balance sheet to allow for the termination of Lees revolving credit facility.... More
After-Hours Stock Movers 01/28: (CNAT) (MTSI) (ARAY) Higher; (XLNX) (BHVN) (CHRW) Lower (more...)
January 28, 2020 5:32 PM ESTToday's After-Hours Stock Movers
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) 17.5% HIGHER; Conatus Pharmaceuticals and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today announced the companies have entered into a definitive agreement under which Histogen will merge with a wholly-owned subsidiary of Conatus in an all-stock transaction. The combined company will operate under the name Histogen, Inc., is expected to trade on the Nasdaq Capital Market under a new ticker symbol still to be determined and will focus on... More
Establishment Labs Holdings (ESTA) Announces Preliminary Results for Q4
January 28, 2020 4:52 PM ESTEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Womens Health initially in the breast aesthetics and reconstruction market today announced preliminary financial results for the fourth quarter and full year 2019, with total revenue growth for the quarter of 43% to 49%.
2019 was another extraordinary year for Establishment Labs, and we ended the year on a strong note with our sixth consecutive quarter of record revenue... More
Establishment Labs Holdings (ESTA) Announces Proposed $55M Share Common Offer
January 28, 2020 4:05 PM ESTEstablishment Labs Holdings Inc. (NASDAQ: ESTA) (the Company), a medical technology company focused on Womens Health initially in the breast aesthetics and reconstruction market today announced that it has commenced a public offering of approximately $55,000,000 of its common shares, to be sold by the Company in a registered public offering. The Company expects to... More

